Distinguishing nontuberculous mycobacterial lung disease from pulmonary tuberculosis using radiomics machine learning models from CT images

利用放射组学机器学习模型从CT图像中区分非结核分枝杆菌肺病和肺结核

阅读:1

Abstract

OBJECTIVES: Develop and evaluate a machine learning (ML) model based on CT radiomics for the identification of non-tuberculous mycobacterial lung disease (NTM-LD) and pulmonary tuberculosis (PTB). MATERIALS AND METHODS: Retrospectively, chest CT images with NTM-LD and PTB patients confirmed at Medical Center 1 between January 2019 to December 2024 were collected. The dataset was divided into a training cohort and a validation cohort in a 7:3 ratio. Additionally, patients from medical center 2 were collected for external test. A radiomics model was constructed using five machine learning algorithms: Logistic Regression (LR), Random Forest (RF), Quadratic Discriminant Analysis (QDA), YeoJohnson_LR, and YeoJohnson_LR (LDA). Receiver operating characteristic (ROC) and area under the curve (AUC) were used to evaluate the diagnostic efficacy of the five models, and the optimal prediction model was obtained. The optimal model was compared with three radiologists in the testing cohort. RESULTS: A total of 1,512 cases were included, including 1,407 cases from Center 1 (NTM-LD: 547; PTB: 860) and 105 patients from Center 2 (NTM-LD: 32; PTB: 73). Patients in the NTM-LD group were significantly older than those in the PTB group (p < 0.001). There was a significant gender difference between the NTM-LD group and the PTB group (p = 0.005). By comparing the five models, it was found that the YeoJohnson_LR (LDA) model was the best-performing prediction model, with an accuracy of 0.8286 in the external test. The AUCs of the YeoJohnson_LR (LDA) model on the training, validation, and test cohort were 0.8421, 0.8037, and 0.8233, respectively. In comparison with radiologists, the YeoJohnson_LR (LDA) model demonstrated gains of 3.12 ~ 15.62% in sensitivity and 6.85 ~ 12.33% in specificity. CONCLUSION: The YeoJohnson_LR (LDA) model can be used to distinguish NTM-LD from PTB, assisting in rapid clinical diagnosis and benefiting patients with NTM-LD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。